期刊文献+

携带人血管生成素-1腺病毒表达载体Padeasy-1/Ang-1的构建、鉴定和滴度测定

Construction,identification and titer detection of adenovirus expression vector Padeasy-1/ Ang-1 carrying human angiopoietin-1
下载PDF
导出
摘要 目的克隆Ang-1基因,构建Ang-1/Pshuttle/Padeasy-1腺病毒表达载体,为进一步研究Ang-1防治卵巢癌病变的血管异质性提供理论基础。方法提取流产胎儿肝脏组织总RNA,RT-PCR扩增出Ang-1基因片段,并将其克隆到Pshuttle载体中进行序列分析,经PacⅠ线性化、连接到腺病毒表达载体Padeasy-1中,将Padeasy-1包装进脂质体、转染入人胚肾293细胞,测定病毒生物活性滴度。结果从流产胎儿肝脏组织总RNA中,扩增出1.4kb的cDNA片段,成功构建了Padeasy-1/Pshuttle/Ang-1表达载体。结论从流产胎儿肝脏组织中成功克隆Ang-1基因,成功构建Padeasy-1/Pshuttle/Ang-1表达载体,Padeasy-1/Pshuttle/Ang-1表达载体的滴度为1×1011PFU/mL。 Objective To clone angiopoietin-1 genes and construct Ang-1/Pshuttle/Pageasy-1 adenovirus expression vector, so as to make theory base for the further research on the Ang-1 prevention and cure blood vessel heterogenous of ovarian caner pathological changes. Methods Extracting mRNA from abortion embryo liver,amplified Ang-1 gene by RT-PCR and cloned into Pshuttle vector and sequenced,linearized by Pac Ⅰ and connected to adenovirus expression vector Padeasy-1, packaging Padeasy into liposome,transfect to 293 cells, determination of virus biological activity titer. Results From abortion embryo liver total RNA, RT- PCR amplified 1. 4kb cDNA fragment, successfully constructing Padeasy-1/Pshuttle/Ang-1 express vector. Conclusion Cloned Ang-1 gene and successfully constructing Padeasy-1/Pshuttle/Ang-1 express vector,it's titer is 1 × 10^11PFU/mL.
出处 《重庆医学》 CAS CSCD 北大核心 2009年第10期1190-1192,共3页 Chongqing medicine
基金 国家自然科学基金资助项目(30600673) "十一五"全军科技计划青年基金项目(06Q054)。
关键词 血管生成素-1 腺病毒载体 基因克隆 angiopoietin-1 adenovirus vector
  • 相关文献

参考文献8

  • 1Camble JR, Drew J, Trezise L, et al. Angiopoietin-1 is an antipermeability and anti-inflammatory agent in vitro and targets cell junctions[J]. Circ Res, 2000,87(7) : 603. 被引量:1
  • 2Hata K, Osaki M, Dhar DK, et al. Evaluation of the antiangiogenic effect of Taxol in a human epithelial ovarian carcinoma cell line [J]. Cancer Chemother Pharmacol, 2004,53(1) :68. 被引量:1
  • 3Zhang L, Yang N, Park JW, et al. Tumor-derived vascular endothelial growth factor upregulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer [J]. Cancer Res, 2003,63 (12) : 3403. 被引量:1
  • 4肖华亮,李增鹏,殷育松,张沁宏,蒋雪峰,卞修武.人脑星形胶质细胞瘤EphB4/ephrinB2表达及与预后的关系[J].第三军医大学学报,2005,27(18):1859-1862. 被引量:5
  • 5Arakelyan L, Merbl Y, Agur Z. Vessel maturation effects on tumour growth., validation of a computer model in implanted human ovarian carcinoma spheroids[J]. Eur J Cancer. 2005, 41(1) :159. 被引量:1
  • 6Vosseler Mirancea N, Bohlen P, Mueller MM, et al. Angiogenesis inhibition by vascular endothelial growth factor receptor-2 blockade reduces stromal matrix metalloproteinase expression, normalizes stromal tissue, and reverts epithelial tumor phenotype in surface heterotransplants[J]. Cancer Res, 2005,65 (4) : 1294. 被引量:1
  • 7Jain RK. Normalization of tumor vasculature : an emerging concept in antiangiogenic therapy [J].Science, 2005,307 (5706) :58. 被引量:1
  • 8Hellmann K. Recognition of tumor blood vessel normalization as a new antiangiogenic concept [J]. Nat Med, 2004,10 (4) :329. 被引量:1

二级参考文献7

  • 1Adams R H, Wilkinson G A, Weiss C, et al. Roles of ephrinB ligands and EphB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis[J]. Genes Dev, 1999, 13(3): 295 -306. 被引量:1
  • 2Tang X X, Brodeur G M, Campling B G, et al. Coexpression of transcripts encoding EPHB receptor protein tyrosine kinases and their ephrin-B ligands in human small cell lung carcinoma [J] . Clin Cancer Res, 1999, 5(2): 455 -460. 被引量:1
  • 3Berclaz G, Flutsch B, Altermatt H J, et al. Loss of EphB4 receptor tyrosine kinase protein expression during carcinogenesis of the human breast[J]. Oncol Rep, 2002, 9(5): 985 -989. 被引量:1
  • 4Andres A C, Reid H H, Zurcher G, et al. Expression of two novel ephrelated receptor protein tyrosine kinases in mammary gland development and carcinogenesis[J]. Oncogene, 1994, 9(5): 1461 - 1467. 被引量:1
  • 5Wang H U, Chen Z F, Anderson D J. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4 [J]. Cell, 1998, 93 (5): 741 - 753. 被引量:1
  • 6Shin D, Garcia Cardena G, Hayashi S, et al. Expression of ephrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization[J]. Dev Biol, 2001,230(2): 139 - 150. 被引量:1
  • 7Adams R H. Molecular control of arterial-venous blood vessel identity [J]. JAnat, 2003, 202(1): 105-112. 被引量:1

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部